Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
45,321
-
Shares change
-
-74,988,790
-
Total reported value, excl. options
-
$2,391,055
-
Value change
-
-$3,523,805,727
-
Number of buys
-
1
-
Number of sells
-
217
-
Price
-
$46.99
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q3 2025
As of 30 Sep 2025 SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) had 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,321 shares of stock of the company.
Largest 10 holders included DekaBank Deutsche Girozentrale, Sanctuary Advisors, LLC, OSAIC HOLDINGS, INC., HUNTINGTON NATIONAL BANK, HIGHLINE WEALTH PARTNERS LLC, CWM, LLC, Trium Capital LLP, Blue Trust, Inc., LOS ANGELES CAPITAL MANAGEMENT LLC, and True Wealth Design, LLC.
This table shows 245 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.